Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.65 - $1.31 $27,885 - $56,200
-42,901 Reduced 12.12%
311,003 $298,000
Q1 2023

May 15, 2023

BUY
$0.38 - $1.07 $10,259 - $28,887
26,998 Added 8.26%
353,904 $265,000
Q4 2022

Feb 13, 2023

SELL
$0.32 - $0.52 $439 - $713
-1,372 Reduced 0.42%
326,906 $120,000
Q3 2022

Nov 14, 2022

BUY
$0.43 - $1.56 $226 - $822
527 Added 0.16%
328,278 $141,000
Q2 2022

Aug 12, 2022

SELL
$0.7 - $1.4 $801,371 - $1.6 Million
-1,144,816 Reduced 77.74%
327,751 $255,000
Q1 2022

May 13, 2022

SELL
$0.63 - $1.59 $137,707 - $347,548
-218,584 Reduced 12.93%
1,472,567 $1.9 Million
Q4 2021

Feb 08, 2022

SELL
$1.27 - $2.42 $179,261 - $341,585
-141,151 Reduced 7.7%
1,691,151 $2.15 Million
Q3 2021

Nov 15, 2021

SELL
$2.15 - $3.82 $61,429 - $109,145
-28,572 Reduced 1.54%
1,832,302 $4 Million
Q2 2021

Aug 13, 2021

BUY
$2.89 - $4.45 $656,966 - $1.01 Million
227,324 Added 13.92%
1,860,874 $6.98 Million
Q1 2021

May 12, 2021

SELL
$2.9 - $4.09 $185,913 - $262,201
-64,108 Reduced 3.78%
1,633,550 $5.33 Million
Q4 2020

Feb 11, 2021

SELL
$3.38 - $5.14 $19,235 - $29,251
-5,691 Reduced 0.33%
1,697,658 $5.79 Million
Q3 2020

Nov 16, 2020

BUY
$2.99 - $4.9 $770,095 - $1.26 Million
257,557 Added 17.81%
1,703,349 $6.95 Million
Q2 2020

Aug 14, 2020

SELL
$2.11 - $3.38 $28,520 - $45,687
-13,517 Reduced 0.93%
1,445,792 $4.89 Million
Q1 2020

May 14, 2020

SELL
$1.83 - $3.45 $31,351 - $59,105
-17,132 Reduced 1.16%
1,459,309 $3.4 Million
Q4 2019

Feb 14, 2020

BUY
$3.5 - $10.35 $112,077 - $331,427
32,022 Added 2.22%
1,476,441 $5.37 Million
Q3 2019

Nov 13, 2019

BUY
$7.03 - $9.7 $1.08 Million - $1.49 Million
153,859 Added 11.92%
1,444,419 $12 Million
Q2 2019

Aug 13, 2019

BUY
$7.36 - $11.26 $193,207 - $295,586
26,251 Added 2.08%
1,290,560 $11.1 Million
Q1 2019

May 13, 2019

BUY
$9.08 - $11.84 $80,802 - $105,364
8,899 Added 0.71%
1,264,309 $13.5 Million
Q4 2018

Feb 12, 2019

SELL
$6.39 - $16.99 $446,315 - $1.19 Million
-69,846 Reduced 5.27%
1,255,410 $11 Million
Q3 2018

Nov 14, 2018

BUY
$16.52 - $24.82 $1.01 Million - $1.52 Million
61,357 Added 4.85%
1,325,256 $22.3 Million
Q2 2018

Sep 18, 2018

SELL
$14.31 - $21.75 $75,499 - $114,753
-5,276 Reduced 0.42%
1,263,899 $26.5 Million
Q2 2018

Aug 14, 2018

BUY
$14.31 - $21.75 $2.73 Million - $4.16 Million
191,125 Added 17.73%
1,269,175 $26.6 Million
Q1 2018

May 09, 2018

BUY
$16.09 - $23.07 $81,737 - $117,195
5,080 Added 0.47%
1,078,050 $17.3 Million
Q4 2017

Feb 14, 2018

BUY
$13.36 - $20.73 $1.14 Million - $1.78 Million
85,680 Added 8.68%
1,072,970 $20.3 Million
Q3 2017

Nov 13, 2017

BUY
$8.75 - $14.07 $8.64 Million - $13.9 Million
987,290
987,290 $13.9 Million

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.